NCT01738334

Brief Summary

Adults with Attention Deficit Hyperactivity Disorder (ADHD) have impairments in attentional subsystems of alerting and conflict monitoring. Mindfulness meditation may lead to an improvement of these deficits, and reduces symptoms of anxiety and depression. However, the studies that demonstrated these improvements did not use a control group, nor controlled the use of medication. In the present study the investigators will examine the effects of the mindfulness practices (same protocol of 8 weekly sessions used in the study that showed positive effects in this disorder) in the performance of adult patients and healthy people (with ADHD). Cognitive performance, mood, and the quality of life will be assessed by validated questionnaires before and after treatment/standby.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2012

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2012

Completed
19 days until next milestone

First Posted

Study publicly available on registry

November 30, 2012

Completed
Last Updated

November 30, 2012

Status Verified

November 1, 2012

Enrollment Period

Same day

First QC Date

November 11, 2012

Last Update Submit

November 28, 2012

Conditions

Keywords

MeditationCognitionAttention Deficit Disorder with Hyperactivity

Outcome Measures

Primary Outcomes (5)

  • Evaluate the ADHD symptoms before to the meditation and after 8 weeks to the meditation.

    The symptoms of inattention and hyperactivity / impulsivity were evaluated by means the Adult self-report scale (ASRS).

    change from baseline in ADHD symptoms at 8 weeks

  • Evaluate the executive functions

    The executive functions tests were applied before to the meditation, so that to avoid learning.

    1 day

  • Evaluate the mood symptoms before to the meditation and 8 weeks after to the meditation.

    The symptoms of anxiety and depression were evaluated by means of the following scales: Trait Anxiety Inventory (STAI-Trait), and Beck Depression Scale, respectively, and the visual-analog scales of mood (VAMS)and Positive and negative Affect Schedule extended (PANAS-X).

    change from baseline in mood symptoms at 8 weeks.

  • Evaluate the quality of life before to the meditation and 8 weeks after to the meditation.

    Quality of Life was evaluated by means of the Questionnaire in Adults with ADHD (AAQoL).

    change from baseline in quality of life at 8 weeks.

  • Evaluate the attention before to the meditation and 8 weeks after to the meditation.

    The scores of attention was evaluated by Continuous Performance Test (CPT) and the Attentional Network Test (ANT).

    change from baseline in attention at 8 weeks.

Study Arms (3)

Healthy subjects

ACTIVE COMPARATOR

The "active" control group of healthy individuals was subjected to the practice of meditation for eight weeks.

Behavioral: Active comparator (meditation) with healthy subjects

Standby

NO INTERVENTION

The control group of participants (patients and healthy subjects) who was not practice anything for eight weeks.

Meditation

EXPERIMENTAL

A Group of Patients with ADHD was participate of the meditation practices for eight weeks.

Behavioral: Meditation

Interventions

The control group with healthy subjects that was participate in meditation ("active" control group)

Healthy subjects
MeditationBEHAVIORAL

In the eight weeks following the first session of cognitive tests, the participants made a practice of weekly meditation group lasting 2 hours. Practices with each group (patients and "active" controls) occurred on different days. With regard to meditation practices were performed in a sitting posture with emphasis on daily life. Each weekly session involved meditation practices with trained professional, practical proposals for home exercise and a discussion group. Meditation compact discs (CDs)were given to participants for practices at home, which proposed activities for 5 minutes to 1 week and 2 weeks for 10 minutes 3-5, and finally 15 minutes for 6-8 weeks. After 8 weeks of treatment the second session of tests was held that involved the same tasks in session 1.

Also known as: Mindfulness
Meditation

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Portuguese as their first language;
  • minimum of eight years of formal education;
  • normal vision or corrected to normal and normal hearing;
  • no prior experience with meditation;
  • patients should be taking stable doses of methylphenidate (for at least a month) for their disorder as prescribed by their doctors.

You may not qualify if:

  • patients with neurological and psychiatric disorders such as psychosis, obsessive-compulsive disorder or Tourette's syndrome.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of São Paulo

São Paulo, São Paulo, 04023062, Brazil

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

MeditationMindfulness

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesCognitive Behavioral Therapy

Study Officials

  • Sabine Pompéia, Postdoctoral

    Federal University of São Paulo

    STUDY DIRECTOR
  • Viviane F Bueno, Doctor

    Federal University of São Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator (Sabine Pompéia)

Study Record Dates

First Submitted

November 11, 2012

First Posted

November 30, 2012

Study Start

February 1, 2012

Primary Completion

February 1, 2012

Study Completion

May 1, 2012

Last Updated

November 30, 2012

Record last verified: 2012-11

Locations